Peptide King Genetics does not have Prince Ru as a person?

Peptide King Genetics does not have the person Prince Ru, Peptide King Genetics legal person is Dr. Yue Wang.

Xiamen Peptide King Gene Science and Technology Co. Legal representative Wang Yue. The company's business scope includes: biological drug manufacturing; hygiene materials and medical supplies manufacturing; health food manufacturing; solid beverage manufacturing; nutritional food manufacturing; instant noodles and other convenience food manufacturing; medical diagnostic, monitoring and therapeutic equipment manufacturing;

Other medical equipment and apparatus manufacturing;

Wholesale of Class III medical devices; Retail of Class III medical devices; Wholesale of health food; Health food retail; medical research and experimental development; spices, flavors and fragrances manufacturing (excluding hazardous chemicals and monitoring chemicals and non-pharmaceutical chemicals); household beauty, health care appliances manufacturing; Class I medical device wholesale; Class II medical device wholesale;

Class I medical device retail;

Class II medical device retail; cosmetics and hygiene products wholesale; Retail sale of cosmetics and hygiene products; import and export of all kinds of commodities and technologies (without separate import and export catalogs), except for those commodities and technologies which the state limits the operation of the company or prohibits the import and export of such commodities and technologies;

export of self-produced products of the enterprise and the import of machinery and equipment, spare parts and raw and auxiliary materials required by the enterprise (without separate import and export catalogs), except for those commodities and technologies which the state limits the operation of the company or prohibits the import and export of such commodities and technologies. Prohibit the import and export of goods and technology, except; engineering and technology research and experimental development; scientific and technological intermediary services.

Xiamen Peptide King Gene Technology Co., Ltd. contained in the advertisements of its food products that "supplementation of active polypeptides is of great importance in the prevention and treatment of cardiovascular, cerebral and cerebral vascular, osteoarthritic, endocrine system, digestive diseases, diabetes and tumors," which violated the provisions of the Chinese People's Code of Conduct (CPC), and the provisions of the Chinese Constitution of the People's Republic of China (CCC). It violates Article 17 of the Advertising Law of the People's Republic of China.

Based on the provisions of Article 55 of the Advertising Law of the People's Republic of China*** and the State, in August 2019, the Market Supervision Administration of Haicang District, Xiamen City, issued an administrative penalty, ordering it to correct its illegal behavior and imposing a fine of 55,4305 yuan.

China Net Finance reporters called Xiamen Peptide King Gene Technology Co. in this regard, and the staff said they were not aware of the matter and could not respond.

Tianyecha shows that Xiamen Peptide King Gene Technology Co., Ltd. was founded in 2016, with a registered capital of 10 million yuan, Wang Yue is the controlling shareholder of the company with 80% of the shares, and Wang Hongshan is the shareholder with 30% of the shares.